文献速递中医内科中医康复中药与中成药合理使用

中药治疗脊髓损伤:随机对照试验的系统评价与Meta分析

Chinese Herbal Medicine in Treatment of Spinal Cord Injury: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
PubMed 文献 · Am J Chin Med · 2020-11-05

该系统评价与Meta分析纳入7个数据库的26项随机对照试验共1961例脊髓损伤患者,评估中药的疗效与安全性。结果显示中药组在ASIA分级改善率、临床有效率、ASIA运动与感觉评分及日常生活活动能力评分方面均优于对照组,未发现严重永久性不良反应,但纳入研究方法学质量较差且证据质量多为极低至中等。

要点

  • 中药可改善脊髓损伤患者的ASIA分级、运动感觉功能及日常生活活动能力。
  • 补阳还五汤是最常用的中药复方,黄芪是最常用的单味药。
  • 纳入研究方法学质量差、样本量小,证据质量极低至中等,需高质量大样本试验验证。

核心结论

  • 当前证据提示中药治疗脊髓损伤有效且安全,可作为副作用较少的补充替代选择。
  • 鉴于纳入研究质量低、样本量小且偏倚风险高,结论需更高质量大样本随机对照试验确认。

研究设计与样本

  • 系统评价与Meta分析,检索7个数据库的随机对照试验。
  • 共纳入26项研究,涉及1961例脊髓损伤患者。
  • 各研究间未观察到严重异质性或发表偏倚。

主要发现

  • 中药组ASIA分级改善率、临床有效率均显著优于对照组。
  • 中药组ASIA运动评分、感觉总分、轻触觉评分、针刺觉评分均显著改善。
  • 中药组日常生活活动能力(ADL)评分显著优于对照组。
  • 两组均未出现严重且永久性的不良反应。
  • 补阳还五汤是最常用的中药复方,黄芪是最常用的单味药。

关键数值与推荐

  • ASIA分级改善率、临床有效率、ASIA运动评分、ASIA感觉总分、轻触觉评分、针刺觉评分及ADL评分均显示中药组优于对照组,具体效应量原文以公式表示未给出数值。
  • 主要结局证据质量按GRADE系统为极低至中等。

临床怎么用

  • 可将中药作为脊髓损伤的补充替代治疗选项,但需结合患者具体情况谨慎使用。
  • 补阳还五汤及黄芪在纳入研究中较常用,但需更多高质量证据支持其确切疗效。

局限性

  • 多数纳入随机对照试验的方法学质量较差。
  • 主要结局的证据质量按GRADE系统为极低至中等。
  • 纳入研究样本量小且偏倚风险高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Spinal cord injury (SCI) is a catastrophic disease associated with damaged neurological structures and has become a significant social and economic burden for the health care system and patients' families. The use of Chinese Herbal Medicine (CHM) to treat SCI has been increasing in recent years. This meta-analysis aimed to investigate the effectiveness of CHM for patients with SCI. Therefore, we included randomized controlled trials (RCTs) of CHM for SCI in seven databases. A total of 26 studies involving 1961 participants were included in this study. No serious heterogeneity or publication bias was observed across each study. The results showed that significant improvements of the American Spinal Injury Association (ASIA)-grading improvement rate ([Formula: see text], [Formula: see text]), clinical effective rate ([Formula: see text], [Formula: see text]), ASIA motor score ([Formula: see text], [Formula: see text]), ASIA sensory score (total) ([Formula: see text], [Formula: see text]), ASIA sensory score (light touch) ([Formula: see text], [Formula: see text]), ASIA sensory score (pinprick) ([Formula: see text], [Formula: see text]), and activities of daily living (ADL) score ([Formula: see text], [Formula: see text]) in CHM group compared with the control group. Among the CHM groups, Buyang Huanwu decoction was the most frequently prescribed herbal formula, while Astragalus membranaceus was the most commonly used single herb. In addition, there were no serious and permanent adverse effects in the two groups. The methodological quality of the most included RCTs was poor and the quality of evidence for the main outcomes was from very low to moderate according to the GRADE system. Current evidence suggests that CHM is an effective and safe treatment for SCI and could be treated as a complementary and alternative option with few side effects. However, considering the low quality, small size, and high risk of the studies identified in this meta-analysis, higher methodological quality, rigorously designed RCTs with large sample sizes are needed to confirm the results.

来源:Am J Chin Med,查看原文。版权归原作者所有。

引用

  1. Zheng Y, Qi S, Wu F, et al. Chinese Herbal Medicine in Treatment of Spinal Cord Injury: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Am J Chin Med. 2020. PMID: 33148008. doi:10.1142/S0192415X20500792

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。